Diseases, Conditions, Syndromes

Ontario should vaccinate newborns for hepatitis B, study suggests

Not all pregnant women are universally screened for hepatitis B virus (HBV) in Ontario, even though this screening is recommended, and the majority of those who test positive do not receive follow-up testing or interventions, ...

Diseases, Conditions, Syndromes

Hospitalizations for chronic liver disease on the rise

(HealthDay)—Hospitalizations for chronic liver disease (CLD) increased from 2012 to 2016, reaching a total estimated national cost of $81.1 billion, according to a study published online April 2 in JAMA Network Open.

Diseases, Conditions, Syndromes

FDA approves mavyret for children, adolescents with hep C

(HealthDay)—Mavyret (glecaprevir and pibrentasvir) tablets are now approved to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17 years, the U.S. Food and Drug Administration announced yesterday.

Diseases, Conditions, Syndromes

WHO targets for chronic hepatitis B will be cost-effective

(HealthDay)—Meeting World Health Organization (WHO) targets for chronic hepatitis B by 2030 will be cost-effective, according to a report published in the July issue of Health Affairs.

Diseases, Conditions, Syndromes

HBcrAg levels tied to progression to cirrhosis in HBV carriers

(HealthDay)—For hepatitis B virus (HBV) carriers, hepatitis B virus core-related antigen (HBcrAg) levels are associated with progression to cirrhosis, according to a study published online Sept. 15 in the Journal of Gastroenterology ...

Diseases, Conditions, Syndromes

Non-liver-related critical events down with SVR in HCV+Cirrhosis

(HealthDay)—For patients with hepatitis C virus (HCV) infection and biopsy-proven cirrhosis, sustained viral response (SVR) is associated with a reduction in critical events, both liver and non-liver related, according ...

page 4 from 11